EL7.AI
StocksMedium•16 November 2026•
3 min read

Bumrungrad Posts Record Third-Quarter Profit of 2,070 Million Baht Despite Limited Annual Growth

Key Facts

1Third-quarter profit reached a record 2,070 million baht, up 2% year on year and 10% quarter on quarter.
2Total revenue reached 6,727 million baht, up 2.2% from the third quarter of 2025.
3Revenue from domestic patients rose 8.2% year on year, compared with a 0.2% increase in revenue from non-Thai patients.
4Non-Thai patients accounted for 65.1% of operating revenue, compared with 34.9% for Thai patients.
5Gross margin was 53.1%, compared with 53.0% in the third quarter of 2025 and 52.2% in the second quarter of 2026.

DBS Research described Bumrungrad Hospital’s third-quarter 2026 profit as a record, at 2,070 million baht, up 2% year on year and 10% quarter on quarter. The firm said the result was in line with market expectations. Data cited by Kaohoon International showed net profit of 2,065 million baht, up 1.5% from 2,035 million baht in the same period a year earlier. Net profit margin was 30.7%. The figures show limited annual growth alongside a more pronounced improvement from the previous quarter.

Total revenue in the quarter was 6,727 million baht, up 2.2% from 6,582 million baht in the third quarter of 2025, according to Kaohoon International. Revenue from hospital operations rose 2.8% year on year to 6,676 million baht. Growth in income from Thai patients was the main driver, rising 8.2% year on year. Revenue from non-Thai patients increased just 0.2%, remaining nearly flat. The divergence in growth rates reflects a larger contribution from domestic demand to quarterly performance, while international patients remained a major revenue source.

Thai patients accounted for 34.9% of operating revenue in the third quarter, up from 33.2% in the same period of 2025, according to Kaohoon International. Non-Thai patients represented the remaining 65.1%. DBS Research estimated international patient revenue at 4.3 billion baht, flat year on year and up 5% quarter on quarter. Domestic patient revenue was 2.3 billion baht, up 8% year on year and 11% quarter on quarter. The quarterly comparison underscores the strength of domestic growth, while international income held steady year on year and improved from the previous quarter.

EBITDA margin was 42.1%, unchanged from the third quarter of 2025 but up from 41.5% in the second quarter of 2026, according to DBS Research. Gross margin also improved to 53.1%, compared with 53.0% a year earlier and 52.2% in the previous quarter. The firm attributed the improvement in gross margin to continued cost savings. For the first nine months of 2026, profit equaled 74% of DBS’s full-year earnings forecast. Among upcoming events, the company scheduled an online analyst meeting to discuss third-quarter results for November 18, 2026, at 2:00 p.m.

DBS Research expects fourth-quarter 2026 profit to grow year on year, while declining from the third quarter. It said pent-up demand following the floods could support activity in the coming period. The outlook also depends on the possibility of a recovery in patient arrivals from the Middle East. Seasonal factors, in contrast, could weigh on the quarter-on-quarter comparison. The forecast therefore points to expected annual growth alongside the possibility of a quarterly decline.